MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 49 filers reported holding MARRONE BIO INNOVATIONS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $82,000 | +57.7% | 75,752 | +4.6% | 0.00% | – |
| Q4 2021 | $52,000 | -21.2% | 72,447 | -0.7% | 0.00% | – |
| Q3 2021 | $66,000 | -48.4% | 72,939 | -5.6% | 0.00% | – |
| Q2 2021 | $128,000 | -18.5% | 77,274 | +2.8% | 0.00% | – |
| Q1 2021 | $157,000 | +67.0% | 75,142 | +0.1% | 0.00% | – |
| Q4 2020 | $94,000 | +11.9% | 75,042 | +8.4% | 0.00% | – |
| Q3 2020 | $84,000 | -17.6% | 69,245 | -20.4% | 0.00% | – |
| Q2 2020 | $102,000 | +25.9% | 87,033 | -12.3% | 0.00% | – |
| Q1 2020 | $81,000 | +15.7% | 99,270 | +42.6% | 0.00% | – |
| Q4 2019 | $70,000 | -29.3% | 69,630 | -0.9% | 0.00% | – |
| Q3 2019 | $99,000 | -5.7% | 70,279 | +0.1% | 0.00% | – |
| Q2 2019 | $105,000 | +1.9% | 70,226 | +4.3% | 0.00% | – |
| Q1 2019 | $103,000 | +3.0% | 67,336 | -1.0% | 0.00% | – |
| Q4 2018 | $100,000 | +16.3% | 68,021 | +44.3% | 0.00% | – |
| Q3 2018 | $86,000 | -1.1% | 47,139 | +0.0% | 0.00% | – |
| Q2 2018 | $87,000 | +123.1% | 47,127 | +364.8% | 0.00% | – |
| Q1 2015 | $39,000 | – | 10,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 10,324,747 | $13,487,000 | 2.13% |
| ICM ASSET MANAGEMENT INC/WA | 258,900 | $388,000 | 0.29% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 561,702 | $843,000 | 0.12% |
| WADDELL & REED FINANCIAL INC | 24,714,892 | $37,072,000 | 0.09% |
| Fairpointe Capital LLC | 291,000 | $436,000 | 0.02% |
| Spark Investment Management LLC | 66,700 | $100,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 2,480,710 | $3,721,000 | 0.00% |
| A.R.T. Advisors, LLC | 18,829 | $28,000 | 0.00% |
| Allworth Financial LP | 11,266 | $17,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 73,678 | $111,000 | 0.00% |